Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

This study has been terminated.
(no change in primary endpoint at week 48)
Sponsor:
Collaborators:
The University of New South Wales
Abbott
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Merck Sharp & Dohme Corp.
Hoffmann-La Roche
AIDS Council of New South Wales
Information provided by:
Kirby Institute
ClinicalTrials.gov Identifier:
NCT00126308
First received: August 1, 2005
Last updated: March 31, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)